ArticleFrontiers in molecular biosciences2026
Site-specific evaluation of mutation-based mimics of histone glycation in the nucleosome.
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Histone glycation is a non-enzymatic post-translational modification (PTM) associated with aging and metabolic stress, yet its residue-specific structural and functional effects remain poorly understood. Because selectively installing defined glycation adducts is experimentally challenging, amino acid substitution by site-directed mutagenesis is commonly used to mimic such PTMs; however, the validity of these substitutions as models of specific glycation adducts has not been systematically assessed. Methods: Here, we performed atomistic molecular dynamics simulations of the nucleosome core particle to compare wild-type systems, advanced glycation end products (AGEs), and substitution-based mimics. Three sites were examined: H2BK43 and H4K31 modified as Nε-(carboxymethyl)lysine (CML), and H3R42 modified as methylglyoxal-derived hydroimidazolone (MG-H1), with glutamine used to mimic CML and tyrosine to mimic MG-H1. Results: Glutamine substitutions used to mimic CML reproduced the direction of local structural changes induced by CML at H2BK43 and H4K31, including increased protein contact, flexibility, and solvent exposure. In contrast, tyrosine substitution did not reproduce the effects of MG-H1 at H3R42, instead markedly reducing DNA engagement and electrostatic interactions. Microsecond-scale simulations further revealed a replicate-dependent propensity for asymmetric DNA entry/exit breathing in systems containing the H3R42Y mutation, a behavior not observed in wild-type or other modified systems. Discussion: These findings indicate that the reliability of mutation-based glycation mimics depends on both the specific glycation chemistry and the local structural context. Consequently, such models should be structurally or biochemically validated before being used to infer nucleosome dynamics or biological consequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.